Astrazeneca Share News (AZN)

Astrazeneca Information

Buy AZN Shares
Add AZN to Watchlist
Add AZN to Alert

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 12,296.00

Bid: 12,322.00

Ask: 12,324.00

Change: -108.00 (-0.87%)

Spread: 2.00 (0.016%)

Open: 12,334.00

High: 12,362.00

Low: 12,250.00

Prev. Close: 12,404.00

Last checked at -

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

Mon, 11th May 2020 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

GOLDMAN SACHS CUTS NEXT TO 'NEUTRAL' ('BUY') - PRICE TARGET 5300 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,000 (7,575) PENCE - 'HOLD'

----------

BRYAN GARNIER RAISES ASTRAZENECA PRICE TARGET TO 8,780 (8,550) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS EASYJET PRICE TARGET TO 746 (945) PENCE - 'OUTPERFORM

----------

MORGAN STANLEY CUTS LAND SECURITIES PRICE TARGET TO 740 (880) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BRITISH LAND PRICE TARGET TO 450 (540) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SEGRO PRICE TARGET TO 980 (950) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES CARNIVAL TO 'BUY' ('HOLD') - TARGET 1280 (3500) PENCE

----------

BERENBERG RAISES OCADO PRICE TARGET TO 2225 (1725) PENCE - 'BUY'

----------

BERENBERG RAISES ST JAMES'S PLACE PRICE TARGET TO 875 (830) PENCE - 'HOLD'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4560 (4730) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BHP GROUP PRICE TARGET TO 1780 (1830) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROLLS-ROYCE PRICE TARGET TO 155 (175) PENCE - 'UNDERWEIGHT'

----------

FTSE 250

----------

MORGAN STANLEY CUTS HAMMERSON TO 'UNDERWEIGHT' ('EQUAL-WEIGHT') - TARGET 50 (175) PENCE

----------

MORGAN STANLEY RAISES LONDONMETRIC PROPERTY TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 200 (210) PENCE

----------

MORGAN STANLEY CUTS SHAFTESBURY PRICE TARGET TO 610 (770) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS GREAT PORTLAND PRICE TARGET TO 720 (920) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS DERWENT LONDON PRICE TARGET TO 3400 (4250) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BIG YELLOW GROUP PRICE TARGET TO 900 (1000) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES IMI PRICE TARGET TO 980 (940) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS UNITE GROUP PRICE TARGET TO 950 (1300) PENCE - 'OVERWEIGHT'

----------

UBS RAISES TRAVIS PERKINS PRICE TARGET TO 1070 (1040) PENCE - 'NEUTRAL'

----------

HSBC CUTS WEIR GROUP TO 'HOLD' ('BUY') - TARGET 985 (1045) PENCE

----------

JPMORGAN CUTS BODYCOTE PRICE TARGET TO 530 (615) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS TATE & LYLE PRICE TARGET TO 740 (770) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BERNSTEIN RAISES BOOHOO TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 415 PENCE

----------

BERENBERG CUTS AA PRICE TARGET TO 20 (30) PENCE - 'SELL'

----------

BERENBERG RAISES BURFORD CAPITAL PRICE TARGET TO 820 (810) PENCE - 'BUY'

----------

RBC CUTS SPIRE HEALTHCARE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 100 PENCE

----------

More News

3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November
no events scheduled
Monday 6 November
Kingspan Group PLC	Trading Statement
Kosmos Energy Ltd	Q3 Results
Ryanair Holdings PLC	Half Year Results
Tuesday 7 November
Associated British Foods PLC	Full Year Results
Beazley PLC	Q3 Results
Direct Line Insurance Group PLC	Trading Statement
dotdigital Group PLC	Full Year Results
IWG PLC	Q3 Results
Persimmon PLC	Trading Statement
RS Group PLC	Half Year Results
Vaalco Energy Inc	Q3 Results
Watches of Switzerland Group PLC	Trading Statement
Wednesday 8 November
Conduit Holdings Ltd	Q3 Results
ITV PLC	Trading Statement
JD Wetherspoon PLC	Q1 Results
Marks & Spencer Group PLC	Half Year Results
MaxCyte Inc	Q3 Results
Secure Trust Bank PLC	Trading Statement
Smiths News PLC	Full Year Results
Time Out Group PLC	Full Year Results
Thursday 9 November
3i Group PLC	Half Year Results
Apax Global Alpha Ltd	Q3 Results
AstraZeneca PLC	Q3 Results
Auto Trader Group PLC	Half Year Results
B&M European Value Retail SA	Half Year Results
Domino's Pizza Group PLC	Trading Statement
Endeavour Mining PLC	Q3 Results
Flutter Entertainment PLC	Trading Statement
IMI PLC	Trading Statement
Indivior PLC	Q3 Results
John Wood Group PLC	Trading Statement
Lancashire Holdings Ltd	Trading Statement
National Grid PLC	Half Year Results
Regional REIT Ltd	Trading Statement
Renewi PLC	Half Year Results
S4 Capital PLC	Trading Statement
Tate & Lyle PLC	Half Year Results
Taylor Wimpey PLC	Trading Statement
TBC Bank Group PLC	Q3 Results
TheWorks.co.uk PLC	Trading Statement
Trakm8 Holdings PLC	Half Year Results
Urban Logistics REIT PLC	Half Year Results
Vistry Group PLC	Trading Statement
WH Smith PLC	Full Year Results
Wincanton PLC	Half Year Results
Wizz Air Holdings PLC	Half Year Results

Copyright 2023 Alliance News Ltd. All Rights Reserved.

1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Latest Share Chat

Astrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

Login to your account

Quickpicks are a member only feature

Login to your account